Nanomedicine News

RSS

Patterned, Functionalized Nanofiber Scaffolds Combined Within Protective 3D Hydrogels for Neural Tissue Reconstruction

It is well known that neurological diseases and injuries pose some of the greatest challenges in modern medicine, with few if any options for effectively treating such diagnoses, but recent work suggests a unique approach for reconstructing damaged neural tissue.

7 Apr 2015

Particle Sciences Receives Notice of Allowance for SATx Disruptive Nanoparticle Platform

Particle Sciences, a leading drug delivery CDMO, has received a Notice of Allowance for composition and use of the technology incorporated into its SATx™ platform.

7 Apr 2015

Systematic Study Analyzes Safety of Upconversion Nanoparticles to Treat Skin Cancer

A group of MIPT researchers together with their colleagues from Moscow, Nizhny Novgorod, Australia and the Netherlands have carried out the first systematic study analyzing the safety of so-called upconversion nanoparticles that may be used to treat skin cancer and other skin diseases. This study is one of the most important steps on the path to new, safe and effective methods to diagnose and treat cancer.

7 Apr 2015

Simvastatin-Loaded Nanoparticles Target Inflamed Immune Cells Within High-Risk Arterial Plaques

A research team showed that a nanotherapeutic medicine can halt the growth of artery plaque cells resulting in the fast reduction of the inflammation that may cause a heart attack, according to a study led by researchers from Icahn School of Medicine at Mount Sinai and published April 3 in Science Advances.

6 Apr 2015

Simple $1 Nanoparticle-Enabled Dynamic Light Scattering Assay Better than Standard Test for Prostate Cancer

A test that costs less than a $1 and yields results in minutes has been shown in newly published studies to be more sensitive and more exact than the current standard test for early-stage prostate cancer.

6 Apr 2015

BIND and Pfizer Extend Global Collaboration for Accurins Targeted Therapeutics

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced an extension of the terms of its global collaboration with Pfizer Inc. to create Accurins that optimize the therapeutic potential of two molecularly targeted oncology drugs in Pfizer’s pipeline.

6 Apr 2015

Nanofibre Gel Drug Delivery Systems May Help Avoid Side Effects of Painkillers

A Chemistry undergraduate at the University of York has helped to develop a new drug release gel, which may help avoid some of the side effects of painkillers such as ibuprofen and naproxen.

3 Apr 2015

Small Gold Nanoparticles Conjugated with miR-182 Sequences Cross Blood-Brain/Blood-Tumor Barrier

Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor.

3 Apr 2015

University of Queensland Antibody for Human Hendra Virus Clinical Trial

An antibody manufactured at The University of Queensland will be used in world-first human Hendra virus clinical trials starting this month.

3 Apr 2015

Kala Reports Top-Line Results from KPI-121 Nanoparticle Loteprednol Etabonate MPP Phase 3 Trial in Cataract Surgery

Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic products based on its proprietary mucus-penetrating particle (MPP) technology, today announced positive top-line results from a Phase 3 clinical trial of KPI-121, its nanoparticle loteprednol etabonate MPP product candidate, for the treatment of inflammation and pain in patients who had undergone cataract surgery.

2 Apr 2015

Nanomedicine News

Patterned, Functionalized Nanofiber Scaffolds Combined Within Protective 3D Hydrogels for Neural Tissue Reconstruction

Particle Sciences Receives Notice of Allowance for SATx Disruptive Nanoparticle Platform

Systematic Study Analyzes Safety of Upconversion Nanoparticles to Treat Skin Cancer

Simvastatin-Loaded Nanoparticles Target Inflamed Immune Cells Within High-Risk Arterial Plaques

Simple $1 Nanoparticle-Enabled Dynamic Light Scattering Assay Better than Standard Test for Prostate Cancer

BIND and Pfizer Extend Global Collaboration for Accurins Targeted Therapeutics

Nanofibre Gel Drug Delivery Systems May Help Avoid Side Effects of Painkillers

Small Gold Nanoparticles Conjugated with miR-182 Sequences Cross Blood-Brain/Blood-Tumor Barrier

University of Queensland Antibody for Human Hendra Virus Clinical Trial

Kala Reports Top-Line Results from KPI-121 Nanoparticle Loteprednol Etabonate MPP Phase 3 Trial in Cataract Surgery

Laser-Induced Graphene for Printable and Biomedical Applications

Mapping Nanomaterial Atomic Structure Without Beam Damage

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Sustainable Hydrogen and Chemical Synthesis via Novel Electrocatalyst

Co-Solvent-Driven Laser Assembly of Gold Nanorods

Breaking Barriers in Thin-Film Deposition with ATLANT 3D’s DALP Technology

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

Sponsored Content

Unlocking Material Behavior at the Microscale Using Nanoindentation

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination